Great progress has been made in many countries to tackle the HIV epidemic. A newly diagnosed patient with access to the latest antiretroviral therapy (ART) can hope to have a normal life expectancy. Yet, over 30 years since the emergence of the virus, and 30 years since the first World’s AIDS Day, much more needs to done to bring these advances to developing countries and to reach groups at high risk of HIV transmission. One of the biggest barriers to achieving this aim is the stigma that is still rife in many countries.
The government pledged to commission PrEP across the board from April 2020, so why are we still in the dark about it?Subscription
There are still no details on how the health and social care secretary’s promise of routine access to HIV prevention treatment will be fulfilled.
One-stop resource for pharmacists in HIV careSubscription
HIV pharmacotherapy: the pharmacist’s role in care and treatment, edited by Jason J Schafer, Jennifer M Cocohoba, Elizabeth M Sherman and Alice L Tseng.
Optimising the health and wellbeing of older people living with HIV in the United Kingdom Subscription
Care for people with HIV has improved, meaning that more people are living with HIV into older age with normal life expectancy. Therefore, there are various challenges and opportunities facing healthcare professionals when providing care to this changing demographic.
The Terrence Higgins Trust has expressed doubt over the government’s ability to meet its deadline of making pre-exposure prophylaxis routinely available on the NHS in England from April 2020.
Almost 30% of UK men who have sex with men 'very likely' to use PrEP if it was availableSubscription
Just under 10% of men who have sex with men in the UK take pre-exposure HIV prophylaxis on demand compared to almost 30% who would be “very likely” to use PrEP if it was available to them.
None of the more than 1,000 people in Wales who have received pre-exposure prophylaxis since it became routinely available have developed HIV while receiving the drugs.
More than a quarter of the sexual health clinics involved in NHS England’s PrEP Impact Trial are currently closed to new recruits, despite a promised expansion, a health minister has revealed.
Rollout of pre-exposure prophylaxis for HIV has resulted in a rapid decrease of new infections among men who have sex with men, according to data collected in New South Wales, Australia.
Study highlights a need for adolescent men who have sex with men to be given pre-exposure prophylaxis and for adherence to be promoted in this group.